NCT04177043View on ClinicalTrials.gov

Model Towards Elimination of Hepatitis C Infection in Egypt: Feasibility and Effectiveness in 73 Villages

PHASE4CompletedINTERVENTIONAL
Enrollment

221,855

Participants

Timeline

Start Date

June 30, 2015

Primary Completion Date

June 30, 2018

Study Completion Date

December 31, 2018

Conditions
Hepatitis C, Chronic
Interventions
DIAGNOSTIC_TEST

HCV antibody and hepatitis B surface antigen (HBsAg) rapid diagnostic tests

HCV antibody and hepatitis B surface antigen (HBsAg) rapid diagnostic tests

DRUG

DAAs

Treatment with different regiments with DAAs

All Listed Sponsors
lead

Egyptian Liver Hospital

OTHER

NCT04177043 - Model Towards Elimination of Hepatitis C Infection in Egypt: Feasibility and Effectiveness in 73 Villages | Biotech Hunter | Biotech Hunter